CASR and Hypocalcemia: The p.Gly66Ser and p.Arg149His Gα 11 mutations were associated with an overall mild increase in CaSR-mediated Ca2+i and MAPK responses, and these findings may explain the mild hypocalcemia observed in the patients harboring these mutations.